Cargando…

Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact

Logistics and (cost-)effectiveness of pharmacogenetic (PGx)-testing may be optimized when delivered through a pre-emptive panel-based approach, within a clinical decision support system (CDSS). Here, clinical recommendations are automatically deployed by the CDSS when a drug-gene interaction (DGI) i...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Wouden, Cathelijne H., Bank, Paul C. D., Özokcu, Kübra, Swen, Jesse J., Guchelaar, Henk-Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628264/ https://www.ncbi.nlm.nih.gov/pubmed/31146504 http://dx.doi.org/10.3390/genes10060416

Ejemplares similares

Development of the PGx‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing
por: van der Wouden, Cathelijne H., et al.
Publicado: (2019)

Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project
por: Blagec, Kathrin, et al.
Publicado: (2018)

Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial
por: Stäuble, Céline K., et al.
Publicado: (2021)

Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)
por: Just, Katja Susanne, et al.
Publicado: (2017)

Assessing the Implementation of Pharmacogenomic Panel-Testing in Primary Care in the Netherlands Utilizing a Theoretical Framework
por: van der Wouden, Cathelijne H., et al.
Publicado: (2020)

Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands
por: Bank, P. C. D., et al.
Publicado: (2019)

Cost-Effectiveness of Pharmacogenomics-Guided Prescribing to Prevent Gene-Drug-Related Deaths: A Decision-Analytic Model
por: van der Wouden, Cathelijne H., et al.
Publicado: (2022)

Potential Benefits of Pre-emptive PGx Testing in Male Breast Cancer Patients
por: Randles, Heather H., et al.
Publicado: (2019)

Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries
por: Blagec, Kathrin, et al.
Publicado: (2022)

Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multi-Center Pilot for Pre-Emptive Pharmacogenomics in Electronic Health Record Systems
por: Rasmussen-Torvik, Laura J., et al.
Publicado: (2014)

PriME-PGx: La Princesa University Hospital Multidisciplinary Initiative for the Implementation of Pharmacogenetics
por: Zubiaur, Pablo, et al.
Publicado: (2021)

Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer
por: Bernard, Philip S., et al.
Publicado: (2021)

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines
por: Lunenburg, Carin A. T. C., et al.
Publicado: (2019)

Pharmacogenomic (PGx) Counseling: Exploring Participant Questions about PGx Test Results
por: Schmidlen, Tara, et al.
Publicado: (2020)

PGx: Putting Peptides to BED
por: Askenazi, Manor, et al.
Publicado: (2015)

Pharmacogenetics in the clinic
por: Guchelaar, H.-J.
Publicado: (2013)

Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group
por: Caudle, Kelly E., et al.
Publicado: (2019)

PGxO and PGxLOD: a reconciliation of pharmacogenomic knowledge of various provenances, enabling further comparison
por: Monnin, Pierre, et al.
Publicado: (2019)

Repurposing of Diagnostic Whole Exome Sequencing Data of 1,583 Individuals for Clinical Pharmacogenetics
por: van der Lee, Maaike, et al.
Publicado: (2019)

Cross-Comparison of Exome Analysis, Next-Generation Sequencing of Amplicons, and the iPLEX(®) ADME PGx Panel for Pharmacogenomic Profiling
por: Chua, Eng Wee, et al.
Publicado: (2016)

HUGO Statement on Pharmacogenomics (PGx): Solidarity, Equity and Governance
Publicado: (2007)

PGxCorpus, a manually annotated corpus for pharmacogenomics
por: Legrand, Joël, et al.
Publicado: (2020)

PGxMine: Text mining for curation of PharmGKB
por: Lever, Jake, et al.
Publicado: (2020)

Drug Use among Nursing Home Residents in Denmark for Drugs Having Pharmacogenomics Based (PGx) Dosing Guidelines: Potential for Preemptive PGx Testing
por: Vermehren, Charlotte, et al.
Publicado: (2020)

Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study
por: Koufaki, Margarita-Ioanna, et al.
Publicado: (2023)

Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics
por: Perwitasari, D. A., et al.
Publicado: (2011)

Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines
por: Manson, Lisanne E. N., et al.
Publicado: (2020)

Pharmacogenomics (PGx) Patient with Mixed Levels of Actionable Variant Evidence
por: Schuh, Michael J., et al.
Publicado: (2020)

The perceptions of pharmacists in Victoria, Australia on pharmacogenetics and its implications
por: McMahon, Teresa, et al.
Publicado: (2011)

Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians
por: Albitar, Lina, et al.
Publicado: (2021)

Independent Community Pharmacists’ Experience in Offering Pharmacogenetic Testing
por: Haga, Susanne B, et al.
Publicado: (2021)

The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S
por: Haga, Susanne B.
Publicado: (2023)

Additional Utility of Pharmacogenomics (PGx) Panel Testing in a CYP2D6 Normal Metabolizer with a History of Breast Cancer
por: Schuh, Michael J.
Publicado: (2019)

Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation
por: Hiratsuka, Masahiro, et al.
Publicado: (2021)

Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review
por: Klomp, Sylvia D., et al.
Publicado: (2020)

Technologies for Pharmacogenomics: A Review
por: van der Lee, Maaike, et al.
Publicado: (2020)

Awareness regarding clinical application of pharmacogenetics among Japanese pharmacists
por: Obara, Taku, et al.
Publicado: (2015)

Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19
por: Swen, J. J., et al.
Publicado: (2011)

Comparison of the Impact of Pharmacogenetic Variability on the PK of Slow Release and Immediate Release Tacrolimus Formulations
por: van Gelder, Teun, et al.
Publicado: (2020)

Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice
por: Tafazoli, Alireza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o3l9spek67qmmtred98n2ltmjb